Literature DB >> 16777503

RETRACTED: Etidronate for fracture prevention in amyotrophic lateral sclerosis: a randomized controlled trial.

Yoshihiro Sato1, Yoshiaki Honda2, Jun Iwamoto3.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Corresponding Author, Yoshihiro Sato, and the co-authors have been informed. Dr. Sato wishes to retract this article on the grounds that it contains fabricated clinical trial data, which he was responsible for producing. In addition, Dr. Sato claims he listed all of the named co-authors without their consent. The co-authors were therefore unaware of the presence of fabricated data in this publication and their participation in the publication. This retraction was initiated by Dr. Sato, and the Editor-in-Chief of Bone was informed by the author directly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16777503     DOI: 10.1016/j.bone.2006.04.025

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

Review 1.  Evolving concepts in neurogenic osteoporosis.

Authors:  Weiping Qin; William A Bauman; Christopher P Cardozo
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

Review 2.  Emergencies in motoneuron disease.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Intern Emerg Med       Date:  2017-03-09       Impact factor: 3.397

3.  ALS-associated mutation SOD1G93A leads to abnormal mitochondrial dynamics in osteocytes.

Authors:  Huan Wang; Jianxun Yi; Xuejun Li; Yajuan Xiao; Kamal Dhakal; Jingsong Zhou
Journal:  Bone       Date:  2017-10-10       Impact factor: 4.398

4.  Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study.

Authors:  Y Guan; F Lv; Y Meng; D Ma; X Xu; Y Song; O Wang; Y Jiang; W Xia; X Xing; J Zhang; M Li
Journal:  Osteoporos Int       Date:  2017-04-24       Impact factor: 4.507

Review 5.  Muscle-Bone Crosstalk in Amyotrophic Lateral Sclerosis.

Authors:  Jingsong Zhou; Jianxun Yi; Lynda Bonewald
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

Review 6.  Etidronate: what is its place in treatment of primary osteoporosis and other demineralizing diseases today?

Authors:  Adriana Ioachimescu; Angelo Licata
Journal:  Curr Osteoporos Rep       Date:  2007-12       Impact factor: 5.096

Review 7.  Bone health and associated metabolic complications in neuromuscular diseases.

Authors:  Nanette C Joyce; Lauren P Hache; Paula R Clemens
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-10-17       Impact factor: 1.784

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.